Abstract: Mechanically sensitive ion channels (MSCs) are ubiquitous. They exist as two major types: those in specialized receptors that require fibrous proteins to transmit forces to the channel, and those in nonspecialized tissues that respond to stress in the lipid bilayer. While few MSCs have been cloned, the existing structures show no sequence or structural homology -an example of convergent evolution. The physiological function of MSCs in many tissues is not known, but they probably arose from the need for cell volume regulation. Recently, a peptide called GsMTx4 was isolated from tarantula venom and is the first specific reagent for mechanosensitive channels. GsMTx4 is a ~ 4kD peptide with a hydrophobic face opposite a positively charged face. It is active in the D and L forms, and appears non-toxic to mice. GsMTx4 has shown physiological effects on cationic MSCs in heart, smooth muscle, astrocytes, and skeletal muscle. By itself, GsMTx4 can serve as a lead compound or as a potential drug. Its availability opens clinical horizons in the diagnosis and treatment of pathologies including cardiac arrhythmia, muscular dystrophy and glioma.
Ion channels sensitive to mechanical stimuli could serve many functions. In higher organisms, specialized exteroceptors transduce sound, vibration, touch, and local gravity. Interoceptors provide feedback for the voluntary musculature and the filling of hollow organs, as in the regulation of blood pressure. Cellular mechanical transducers provide local control of blood flow, regulation of cell volume, stress-dependent deposition of bone, etc. The hormonally coupled mechanical systems, including renin and atrial naturietic peptide, regulate fluid volume. There are also autocrine and paracrine transducers that generate chemical messengers such as endothelin. Some of these processes are probably triggered by mechanosensitive channels (MSCs) [1] .
Mechanical transduction appears to be present in all phyla. In plants, mechanical transducers guide root, stem and leaf growth (the roots go down and the stems go up). In microorganisms, MSCs may serve as sensory transducers for sensory functions including volume regulation in prokaryotes. The importance of MSC function is underscored by the presence in E. coli of four different MSCs [2] . This suggests that mechanical transduction developed early in evolution.
The ubiquitous nature of MSCs indicates that we will find genetic links to human pathology. For example, dystrophic muscle has a genetic defect in dystrophin that reinforces the membrane. However, the resulting pathology appears to result from increased Ca ++ influx, probably through MSCs [3] rather than through tears in the membrane. The excess influx can be blocked by gadolinium, a nonspecific inhibitor of MSCs [4] .
Our current thinking is that there are two basic kinds of mechanically sensitive channels. The first kind is found in specialized sensory cells where they are activated by forces applied directly through fibrous proteins. These occur in *Address correspondence to the author at the Center for Molecular Biophysics, 301 Cary Hall, SUNY, Buffalo, NY 14214, USA Tel: 716 829 3289; E-mail: philgott@buffalo.edu cochlear hair cells and the nematode touch sensory neurons [5, 6] . The second kind of MSC is sensitive to stress in the lipid bilayer [7] [8] [9] . While "classic" MSCs are channels whose kinetics are substantially altered by mechanical inputs, some channels previously characterized as predominately voltage or ligand dependent, such as Kv1.4, are also mechanically sensitive [10] [11] [12] .
The key parameter that makes channels mechanosensitive is large dimensional changes between the closed and open conformations. For channels deriving their gating energy from bilayer tension [13] , the energy difference between the open and closed states at tension T is ∆G=T * ∆A, where ∆A is the change of in-plane area between the closed and open states [13] . For the bacterial channel MscL, which is strongly biased to be closed, this energy can be >50kT [14] , corresponding to a change in radius from 5-6 nm [15] . Secondary contributions to the free energy for gating, such as hydrophobic mismatch, may accompany the area change because the channel thins as it widens [16] .
In this review we will describe our current understanding of mechanosensitive channels that respond to lipid tension, and some possible therapeutic targets associated with activity of these channels.
MECHANOSENSITIVE CHANNELS ARE NOT HOMOGENEOUS
Mechanosensitive channels are not homologous. Although mechanically sensitive ion channels appear present in the cells of all phyla, homologous structures have yet to emerge. This suggests that they may have evolved multiple times. For example, in E. coli, the two dominant mechanosensitive channels (generically noted MSCs) differ fundamentally in sequence and structure. MscL is a pentamer and MscS is a heptamer [17, 18] , and the primary sequences of the subunits have little homology. Two well characterized MSCs cloned from eukaryotes are the K + selective TREK-1 and TRAAK [19, 20] , and a cationic TRP channel from the yeast vacuole [21] . These have no useful sequence homology Fig. (1) . Structure of GsMTx4. Blue is positive, red is negative, and green is hydrophobic.
to the bacterial channels. Thus, mechanosensitivity, while universal, does not seem to obey the delightful homologies of many of the voltage and ligand gated channels. Moreover, since the exo-and cyto-skeletal structures of bacteria are so different from eukaryotes, and these structural elements affect the distribution of mechanical stress, we should expect little homology. Lessons learned from bacterial MSCs may not apply to eukaryotic MSCs.
Despite their ubiquity, the physiological function of MSCs channels in non-specialized tissues is unknown. To test the physiological role of channel function, one needs to activate or inactivate them by non-physiological stimuli. Specific pharmacologic agents are one approach, genetic knockouts are another, but the latter has not yet been exploited. It may be surprising to realize that there is only one specific pharmacological agent that acts on MSCs. The search was hampered, in part, by technical difficulties in defining the stimulus. Stimulators for electrically activated channels and for ligand-gated channels are available, but not till this year has one been commercially available for MSCs. However, the actual stimulus that reaches a channel depends critically upon the geometry and mechanical properties of the cell cortex, factors that are generally unknown. Applying a precise amount of suction to a patch pipette does not define the force reaching the channel.
PHARMACOLOGY
Since MSCs form a wide-ranging family, it is unlikely that there is "a blocker" any more than we have "a blocker" for the voltage or ligand gated families. Gd 3+ , a lanthanide the size of Ca 2+ , is an effective inhibitor (10-20µM) for many MSCs is not specific. Amiloride and some of its derivatives will block indigenous MSCs in Xenopus öocytes at 20-100 µM [22] , as will cationic antibiotics such as streptomycin [23] [24] [25] , but these too are not specific.
Amphipaths, compounds with hydrophobic and hydrophilic regions, can affect MSCs, probably by altering the local membrane curvature, the boundary lipids, [26] [27] [28] as in red cells [29, 30] . The amphipaths alter the relative tension in the two monolayers that make up the bilayer, resulting in changes of curvature. Intriguingly, the inhalational anesthetics, such as chloroform are amphipaths, and activate K + selective neuronal TREK channels at therapeutic concentrations [31] . This suggests a significant role for MSCs in anesthesia, and the mechanosensitivity of K channels in general [10] may explain why a blow to the head can cause unconsciousness.
As with voltage gated channels, significant progress in our understanding of MSC structure and function awaits specific inhibitors. Since venomous animals have evolved a wide arsenal of peptide toxins for prey capture and defense, and these venoms have been a rich source of inhibitors for voltage sensitive channels, we screened arachnid venoms for possible MSC inhibitors (arachnids don't have phospholipases in the venom, simplifying the assay). Lewis and Garcia [32] have recently compiled the structure, function, pharmacological properties and clinical potential of some well known peptides derived from venoms.
Fig. (2).
Inhibition of cationic mechanosensitive channels in primary human bladder smooth muscle cells by 5 µM GsMTx4. The stimulus (pipette pressure) is shown in blue. When the stimulus under control conditions, the current increases (black trace). In the presence of GsMTx4, the same stimulus produces no current (red trace).
PEPTIDE INHIBITOR OF MSCS
We isolated a peptide from the venom of tarantula that affects the activity of mechanosensitive ion channels in eukaryotic cells [33] . The primary amino acid sequence was deduced from the nucleotide sequence [34] and the solution structure was determined by NMR [35] . The peptide, called GsMTx4, is a member of the inhibitory cysteine knot (ICK) toxin superfamily [36] that contains many peptides, some active on voltage dependent channels.
These peptides have a folding pattern formed by three disulfides in a triple stranded β-sheet structure, which has one disulfide threaded through an embedded ring formed by the other two [37] . The multiple disulfide bonds of the ICK motif, and its cousin, the growth factor cysteine knot [38] , fold small peptides into compact structures. This rigid scaffolding fixes the relevant side chains in space and simultaneously makes the peptides resistant to enzymatic digestion. Typically, these peptides have a hydrophobic core and face, and are positively charged [37] . The hydrophobic face suggests a role in lipid binding [39] .
GsMTx4 blocks stretch-activated channels in rat astrocytes and chick heart cells with a K d of 500nM [33, 40] . There are two basic modes of action when considering channel inhibition: the inhibitor is either a pore blocker, or it is a gating modifier. A telltale sign of a gating modifier is that it shifts the dose-response curve shifts to the right so an increase in the stimulus can restore channel activity. By this criteria, we know GsMTx4 to be a gating modifier instead of a pore plugger [28] . The ICK peptides active on voltage sensitive channels seem also to act as gating modifiers [41] . We have shown that stretch activated channels in chick heart [28] , rat astrocytes [33] , and human bladder and kidney cells are inhibited by GsMTx4 (Fig. (2) ).
Unlike voltage gated channels where the charged S4 domains are responsible for sensing voltage [42] , MSC gating probably involves a more global response [43] . The channel must undergo a large change in dimensions to gain energy from the membrane tension [14] . Due to the lack of structural information on cationic MSCs, the mechanism by which GsMTx4 inhibits MSCs is not known. Nonetheless, there are three general mechanisms to be considered. The first is that peptide binds to the bulk membrane, and by altering the global curvature produces a stress on the channels. The second is that the peptide binds to boundary lipids surrounding the channel and alters the local environment. The third possibility is the traditional model of lock and key style protein-protein interactions [44, 45] .
To test for direct peptide-protein interactions, we synthesized the mirror imaged molecule using D amino acids [28] . The logic of this experiment is that direct chemical interactions, such as hydrogen bonding, would be unavailable to the D form because of the mirror-image geometry. On the other hand, the general physical properties would be maintained and they would be identical to the Lform peptide. In this scenario, if the peptide acted through the non-chiral lipids, then the activity would be identical for either enantiomeric form. Physically, the D-form behaved identically to the L-form, except for a reversed CD spectrum. For example, both peptides had the identical retention time in reverse phase chromatography. When we tested the Dform peptide at 500nM in a patch clamp assay, the D enantiomer was equivalent to the L-form, suggesting that the peptide was interacting with the membrane lipids. If the peptide was acting within a Debye length of the channel pore, then its charge of +5 at neutral pH would cause a reduction of conductance for inward current (cations), but not outward currents whose ions are approaching from the opposite side of the membrane. Our measurements have confirmed this prediction [39] . It now appears that the primary mode by which the peptide mediates its effect is at the membrane-channel interface. A similar mechanism has been suggested for voltage gated channels [41] .
GsMTx4 is remarkably specific given its apparent lipidbased site of action. It does not affect voltage gated channels in rat astrocytes [33] , or rabbit heart [46, 47] . It has no Fig. (3) . Left panel, SD's leading to bursts of action potentials. Right panel; blockade of SDs and arrhythmias by GsMTx4 with virtually no effect on the normal action potential. (Data courtesy of Dr. Clive Baumgarten). Fig. (4) . Block of dilation potentiated atrial fibrillation (AF) by 170nM GsMTx4 in the Langendorff perfused rabbit heart (from [59] with permission). Atrial fibrillation was induced by a burst of rapid electrical stimulation, and we have plotted the frequency with which that resulted in AF. Inflation increased the probability of AF (open symbols), but GsMTx4 markedly shifted the dose-response curve to higher pressures (filled symbols).
significant effect on the beating rabbit or sheep heart, unless the heart is distended. Preliminary experiments have shown that injection of GsMTx4 into mice (at four times the K d of MSCs assuming distribution in the blood volume) produces no behavioral change except for reduced water consumption over 24 hours, perhaps by acting on the thirst center of the hypothalamus [48] (Suchyna et al., in preparation). Even among MSCs, GsMTx4 is specific as it doesn't affect auditory transduction [49] or the activity of TREK channels (E. Honore, personal communication). The basis of this specificity is unclear, but may reside in the affinity of the peptide for particular boundary lipids near MSCs, or perhaps because these channels are more sensitive to the local environment than other channels.
An unintended outcome of these studies is the realization that the enantiomeric peptide can serve as a therapeutic agent. Since the D-form of peptides are more resistant to hydrolysis by natural proteases [50, 51] and GsMTx4 is amphipathic, it may be a good lead compound for a oral drug.
POTENTIAL CELLULAR TARGETS Cardiac Myocytes and Atrial Fibrillation
The initiation of arrhythmias is a classic effect of stretch on the heart [46, 47] , and the connection between mechanical stress and excitability in the heart (known as mechanoelectric feedback) has been appreciated for over a century [52, 53] . This is not a trivial modulation of ongoing activity -the ventricles of an intact heart can be stimulated to repeatedly contract in phase with inflation of an intraventricular balloon [54] . There have been numerous studies showing that stretch can affect both the cardiac action potential and whole cell currents [47] . Mechanically sensitive channel activity have been observed in heart cells [55, 56] by many different laboratories. Recently, a mechanosensitive maxiK channel was cloned from chick heart [57] . Given the presence of mechanosensitive ion channels, pharmacological agents that affect the channels are likely to produce functional effects, such as inhibiting stress-induced arrhythmias. Marban's group described an arrhythmia where termination of high speed pacing leads to spontaneous depolarizations (SDs) [58] . The arrhythmia was not blocked by any standard pharmaceutical agents, and to quote the authors, "The frequent occurrence of SD points to a novel cellular mechanism for abnormal automaticity in heart failure". Baumgarten and Clemo recently repeated this experiment on isolated rabbit ventricular and atrial cells and found the same result (personal communication). However, they found that GsMTx4 blocked the SDs (Fig. (3) ). While the origin of the arrhythmia has not been worked out, it is possible that high speed pacing overloads the SR causing Fig. (5) . Stretch applied during contraction (eccentric contractions) in dystrophic and wt muscle leads to elevated Na + . Panel A shows a graph of sodium green fluorescence during isometric and eccentric contractions to mdx and wt muscle fibers. The fluorescence increase in mdx fibers was significantly greater than in wt fibers. Panel B and C show an mdx fiber before and after eccentric contraction (after [3] , with permission).
spontaneous Ca 2+ release. This in turn could cause local contractions, and by the non-uniform stress, activate mechanosensitive ion channels -source of the inward currents. The surprising effect of GsMTx4 on this arrhythmia may be a prototype of how these compounds can be used for physiological diagnosis of MSC function, as well as serving as lead compounds for drug development.
In a study of stretch-induced arrhythmias (Fig. (5) ), 170 nM GsMTx4 blocked atrial fibrillation in Langendorff perfused rabbit hearts. Fibrillation was potentiated by inflating the atrium [59] . GsMTx4 provided complete protection against fibrillation up to a diastolic pressure of 15mmH 2 O, and it shortened the duration of fibrillation at all pressures. In the unstressed heart, ionotropy and the action potential were unaffected by GsMTx4. Even at nearly 10X the K d for SACs, the action potential of resting atrial cells was unaffected [47] .
Muscular Dystrophy
An intriguing connection between stretch-activated channels and physiological abnormalities exists for the muscular dystrophies characterized by mutations to proteins in the dystro-glycan complex (DGC). The DGC is a multiprotein group that connects the internal actin cytoskeleton to the extracellular matrix through attachments to laminin (reviewed in [60] ). In between are a number of linking and accessory proteins, many of which are intramembrane proteins. Together, they provide structural support to the bilayer. Mutations in this complex lead to different forms of muscular dystrophy that vary in severity, susceptible muscle groups, and the age of phenotypic onset [61] . Duchenne Muscular Dystrophy (DMD) is the most common of these disorders, caused by mutations to the large cytoskeletal protein dystrophin. Most dystrophies associated with mutations to proteins in the DGC are characterized by elevated internal Na + and Ca +2 levels (Fig. (5) ), and excessive protein degradation [62] . Thus, a major strategy for acute therapy development has been to improve Ca +2 homeostasis [61] .
Franco-Obregon and Lansman [63, 64] have studied the effect of repeated application of a pressure stimulus on membranes from mouse mdx myoblasts (mouse DMD model) as compared to the wild type counterpart. They demonstrated that stretch activated channels in mdx cells become hyperactive with prolonged stimulation, as though a reinforcing structure was being disrupted. They propose a decoupling mechanism whereby disruption of viscoelastic elements associated with the membrane leads to a loss of membrane tension regulation and thus increased channel open probability. Suchyna and Sachs [40] and others [65, 66] have shown that MSCs also inactivate in time. In rat astrocytes, channel activation closely follows the change in membrane tension. Fig. (6) . Averaged SAC currents from primary astrocytes (red) inactivate with time, while membrane stress (recorded as patch capacitance) continues to increase with time (green) [40] . Fig. (7) . Cation SACs in astrocytes are Ca 2+ permeant. Single channel currents from astrocytes (outside-out patches) with the pressure stimulus applied during the bar. Fig. (6) . but inactivation is not tension sensitive. However, inactivation, which is only accessible through the open states, depends on cytoskeletal integrity [40] . This raises the possibility that hyperactivity of SACs in dystrophic muscle might be the result of both an increase in activation due to increased membrane stress, and a breakdown of channel inactivation.
Cation selective SACs are highly permeable to Ca +2 [67] , implicating them as the potential source of the Ca +2 leak plaguing these cells (Fig. (7) ).
Work by Yeung et al. [3] has linked the pathology of mdx muscle fibers with the influx of cations through SACs. They showed that both gadolinium and streptomycin, nonspecific blockers of SACs, reduce elevated sodium levels in stretched mdx fibers while having little effect on normal muscle fibers. They postulated that cation selective stretchactivated channels in mdx fibers are responsible for the increased influx of Na + and Ca +2 . Furthermore, Na + influx can lead to additional Ca 2+ influx through the Na + /Ca 2+ exchanger [68, 69] .
Research on therapies for dystrophy has centered on a genetic cures to correct the primary defect. However, as stated in a recent review, "these approaches face a number of technical hurdles. Immunological responses against viral vectors, myoblasts and newly synthesized dystrophin have been reported, in addition to toxicity, lack of stable expression, and difficulty in delivery." [61] . Pharmacological approaches offer a more immediate potential for ameliorating the pathology. In the near future, gene-and pharmacological-based strategies will likely be used in combination to produce the highest potential therapeutic effects. We are currently evaluating the efficacy of GsMTx4 as a therapeutic agent in mdx mice.
Astrocytes and Gliosis
Astrocytes are the most abundant cells in the CNS. They secrete substances that act on themselves, on other types of glia, vascular endothelial cells and neurons [70] . They play an important role in the induction and maintenance of the blood-brain barrier [71] and communicate intracellular Ca 2+ signals bidirectionally with neurons [72] [73] [74] .
We have demonstrated that stretch-activated channels exit in astrocytes and investigated their physiological role. Endothelin (ET) is a potent autocrine mitogen produced by reactive and neoplastic astrocytes. The relationship between mechanical stretch and ET production in other cell types, combined with the observation that ET-1-positive reactive astrocytes appear in the mechanically deformed periphery of CNS pathology, led us to hypothesize that mechanical stress may regulate ET in astrocytes.
Ostrow and Sachs demonstrated that mechanical stimulation of adult rat astrocyte cultures causes a dramatic increase in ET-1 production and secretion into the culture medium [75] . These experiments represented the first demonstration that the astrocytic endothelin system can be directly stimulated by cell deformation. Since virtually all brain pathology is associated with some degree of mechanical deformation of the surrounding parenchyma, and ET induces the proliferation of astrocytes (and glioma cells), the possibility arises that mechanical induction of the ET s y s t e m represents a general pathway for activating/augmenting astroglial proliferation. ET-1 exerts its mitogenic effects in most cell types, including astrocytes and glioma cells, by affecting Ca 2+ homeostasis, possibly explaining how endothelin potentiates its own production and secretion [76] [77] [78] [79] [80] [81] . Non-mechanical stimuli including growth factors and cytokines can also enhance ET expression in astrocytes [82] [83] [84] [85] [86] . Regardless of the stimulus, alterations in cell Ca 2+ seems to be the common link in regulating the endothelin system in all cell types [82, 83, 87-90, 90, 91] . The Ca 2+ effects seem to ultimately depend on activation of the mitogen-activated protein kinase (MAPK) pathway and the induction of phospholipase C (PLC) and protein kinase C (PKC) [84] .
Given the connection between SACs and endothelin production, an inhibitor of these channels could provide a novel therapeutic approach by controlling a mitogen whose overproduction is associated with pathological states. Additionally, Vaz et al. [92] demonstrated that the degree of edema following head trauma is reduced by the nonspecific SAC inhibitors gadolinium, amiloride, and gentamicin, implying that SACs are involved in the swelling. Having already demonstrated that GsMTx4 blocks SACs in astrocytes, we showed it also inhibits the stretch-induced ET-1 production by astrocytes. GsMTx4 does not alter basal ET secretion in the absence of stretch, illustrating the specific nature of its action. As expected, stretch-induced ET secretion was also decreased by lowering extracellular Ca 2+ [93] .
Glioma growth could occur in a cycle that follows a local defect that causes tissue enlargement. Forces arising from excess growth would press against the surrounding tissue causing activation of SACs and then secretion of ET-1. This, in turn, would stimulate further division and vascular invasion. The "lump" would increase in size closing the loop. An inhibitor of SACs might slow glioma development. Particularly appealing is the use of the D form of GsMTx4, since it is non-hydrolysable, significantly hydrophobic, and might be taken orally. It is not yet known whether GsMTx4 will cross an intact blood-brain barrier, but it is known that the barrier can be temporarily relaxed [94] .
Outlook
There must be pathologies associated with the malfunction of MSCs, but without specific probes, it has not been possible to diagnose their involvement. Genetic mapping has not yet provided any results to suggest MSCs contributing to pathology, probably because of a lack of assays. A potentially interesting pathology to be mapped is rippling muscle disease, in which skeletal muscles become sensitive to mechanical inputs [95, 96] . MSCs seem to serve mild modulatory roles; our preliminary experiments show that GsMTx4 is non-toxic to mice. Without fatal consequences, genetic defects in mechanical sensors are likely to be common. We look forward to progress with histologic and genetic mapping.
